Investigation of biochemical and haematological side-effects of cefquinome in healthy dogs

Veterinary Quarterly

Volumn 23, Issue 1, 2001, Pages 32-34

  Maden, M ^a   Birdane, F M ^a   Tras B ^a   Bas A L ^a   Elmas, M ^a   Yazar, E ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CEFQUINOME; CEPHALOSPORIN; COBACTAN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; BLOOD TOXICITY; BODY WEIGHT; DOG; DRUG EFFECT; FEMALE; MALE; NONHUMAN; PARAMETER; PATHOGENESIS;

ANIMALS; BIOCHEMICAL PHENOMENA; BLOOD GAS ANALYSIS; CEPHALOSPORINS; DOGS; FEMALE; HEMODYNAMIC PROCESSES; INJECTIONS, INTRAMUSCULAR;

EID: 0035136398     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.2001.9695072     Document Type: Article

References (13)

1. Bottncr A, Schmid P, and Humke R. In vitro efficacy of cefquinomc (INN) and other anti-infective drugs against bovine bacterial isolates from Belgium, France, Germany, The Netherlands, and the United Kingdom. Zentralbl Vctcrinarmcd (B) 1995; 42 (6); 377–83.
2. Caprile KA. The cephalosporin antimicrobial agents: a comprehensive review. J Vet Pharmacol Therap 1988; 11: 1–32.
3. Fckety FR. Safety of parenteral third-generation cephalosporins. Am J Med 1990; 88 (4A): 38S-44S.
4. Ilautekcete ML. Hepatotoxicity of antibiotics. Acta Gastroenterol Bcle 1995; 58 (3-4); 290–6.
5. 1” ed. p.822-49. Iowa State University Press, Ames, 1988.
6. th Ed, s: 303-389. Guncs Kitabevi Ltd. Sti., Ankara 1994.
7. Kunkle GA, Sundlof S, and Keisling K. Adverse side effects of oral antibacterial therapy in dogs and cats: an epidemiologic study of pet owners’ observations. J Am Anim Hos Ass 1995; 31:46–55.
8. Lubran MM. Hematologic side effects of drugs. Annals of Clinical and Laboratory Science 1989; 19:114–21.
9. Meyer DJ, Coles EH, and Rich LJ. Veterinary Laboratory Medicine. Interpretation and Diagnosis. W.B. Saunders Company, London, 1992.
10. Pelletier LL. Cefprozil versus cefaclor in treatment of bronchitis in the elderly. Drug Invest 1994; 8:263–70.
11. Shpigcl NY, and Schmid P. Contribution to the treatment of acute bovine mastitis with cefquinomc. Ticrarztl Prax 1997; 25:200–6.
12. Shpigcl NY, Levin D, Winkler M, Saran A, Ziv G, and Bottner A. Efficacy of cefquinomc for treatment of cows with mastitis experimentally induced using Escherichia coli. J Dairy Sci 1997; 25 (3): 318–23.
13. Vial T, Biour M, Dcscotcs J, and Trepo C. Antibiotic-associated hepatitis: update 1990. Annals of Pharmacotherapy 1997; 31:204–20.